Indian Army Procurement of Essential Drugs and Medical Consumables

This tender, issued by the Department of Military Affairs under the Ministry of Defence, presents a significant opportunity for suppliers of essential pharmaceutical products. With Bid Number GEM/2026/B/8182359, the Indian Army is seeking to procure a comprehensive range of drugs and consumables, as detailed in the Bill of Quantities (BOQ). The tender period commences on November 14, 2026, at 2:00 PM and concludes on November 16, 2026, at 2:00 PM. The procurement encompasses a diverse list of medications, including Azathioprine 50 mg tablets, Fluconazole 200 mg capsules/tablets, Dapaglifozin 5 mg tablets, Pioglitazone 30 mg tablets, Isosorbide mononitrate 30 mg tablets, Digoxin 0.25 mg tablets, Serratiopeptidase 10 mg tablets, Solifenacin 5 mg tablets, Clonidine 100 mcg tablets, Brinzolamide 1 percent eye drops, Rosuvastatin 40 mg tablets, Memantine 10 mg tablets, Fluticasone furoate 100 mcg plus vilanterol 25 mcg rotacaps, Inj. normal saline 100 ml, Ginkgo biloba tablets, Sodium valproate 300 mg tablets, Anastrazole 1 mg tablets, Carbidopa 25 mg plus Levodopa 100 mg CR tablets, Fexofenadine 180 mg tablets, Pirfenidone 200 mg, Gabapentin 300 mg plus methylcobalamin 500 mg tablets, Povidone iodine 200 mg vaginal pessaries, Pyridoxin 40 mg tablets, Spironolactone 50 mg tablets, Clotrimazole dusting powder (bottle of 100 gm candid foot powder), Naproxen 250 mg tablets, and Formoterol 6 mcg plus Glycopyrrolate capsules. The total quantity required for this critical supply is 40,915 units, ensuring a substantial demand for qualified and capable suppliers.